RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia

Anna R. Poetsch; Daniel B. Lipka; Tania Witte; Rainer Claus; Peter Nöllke; Manuela Zucknick; Christiane Olk-Batz; Silvia Fluhr; Michael Dworzak; Barbara De Moerloose; Jan Starý; Marco Zecca; Henrik Hasle; Markus Schmugge; Marry M. van den Heuvel-Eibrink; Franco Locatelli; Charlotte M. Niemeyer; Christian Flotho; Christoph Plass

doi:10.4161/epi.29941

RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia

Anna R. Poetsch, Daniel B. Lipka, Tania Witte, Rainer Claus, Peter Nöllke, Manuela Zucknick, Christiane Olk-Batz, Silvia Fluhr, Michael Dworzak, Barbara De Moerloose, Jan Starý, Marco Zecca, Henrik Hasle, Markus Schmugge, Marry M. van den Heuvel-Eibrink, Franco Locatelli, Charlotte M. Niemeyer, Christian Flotho, Christoph Plass

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

28 Citaten (Scopus)

Samenvatting

Aberrant DNA methylation at specific genetic loci is a key molecular feature of juvenile myelomonocytic leukemia (JMML) with poor prognosis. Using quantitative high-resolution mass spectrometry, we identified RASA4 isoform 2, which maps to chromosome 7 and encodes a member of the GAP1 family of GTPase-activating proteins for small G proteins, as a recurrent target of isoform-specific DNA hypermethylation in JMML (51% of 125 patients analyzed). RASA4 isoform 2 promoter methylation correlated with clinical parameters predicting poor prognosis (older age, elevated fetal hemoglobin), with higher risk of relapse after hematopoietic stem cell transplantation, and with PTPN11 mutation. The level of isoform 2 methylation increased in relapsed cases after transplantation. Interestingly, most JMML cases with monosomy 7 exhibited hypermethylation on the remaining RASA4 allele. The results corroborate the significance of epigenetic modifications in the phenotype of aggressive JMML.

Originele taal-2	Engels
Pagina's (van-tot)	1252-1260
Aantal pagina's	9
Tijdschrift	Epigenetics
Volume	9
Nummer van het tijdschrift	9
DOI's	https://doi.org/10.4161/epi.29941
Status	Gepubliceerd - 2014
Extern gepubliceerd	Ja

Toegang tot document

10.4161/epi.29941

Citeer dit

Poetsch, A. R., Lipka, D. B., Witte, T., Claus, R., Nöllke, P., Zucknick, M., Olk-Batz, C., Fluhr, S., Dworzak, M., De Moerloose, B., Starý, J., Zecca, M., Hasle, H., Schmugge, M., van den Heuvel-Eibrink, M. M., Locatelli, F., Niemeyer, C. M., Flotho, C., & Plass, C. (2014). RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia. Epigenetics, 9(9), 1252-1260. https://doi.org/10.4161/epi.29941

@article{db1c3881e96f4122b5b1504bdc0856f5,

title = "RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia",

abstract = "Aberrant DNA methylation at specific genetic loci is a key molecular feature of juvenile myelomonocytic leukemia (JMML) with poor prognosis. Using quantitative high-resolution mass spectrometry, we identified RASA4 isoform 2, which maps to chromosome 7 and encodes a member of the GAP1 family of GTPase-activating proteins for small G proteins, as a recurrent target of isoform-specific DNA hypermethylation in JMML (51% of 125 patients analyzed). RASA4 isoform 2 promoter methylation correlated with clinical parameters predicting poor prognosis (older age, elevated fetal hemoglobin), with higher risk of relapse after hematopoietic stem cell transplantation, and with PTPN11 mutation. The level of isoform 2 methylation increased in relapsed cases after transplantation. Interestingly, most JMML cases with monosomy 7 exhibited hypermethylation on the remaining RASA4 allele. The results corroborate the significance of epigenetic modifications in the phenotype of aggressive JMML.",

keywords = "DNA methylation, Epigenetics, JMML, juvenile myelomonocytic leukemia, RASA4",

author = "Poetsch, {Anna R.} and Lipka, {Daniel B.} and Tania Witte and Rainer Claus and Peter N{\"o}llke and Manuela Zucknick and Christiane Olk-Batz and Silvia Fluhr and Michael Dworzak and {De Moerloose}, Barbara and Jan Star{\'y} and Marco Zecca and Henrik Hasle and Markus Schmugge and {van den Heuvel-Eibrink}, {Marry M.} and Franco Locatelli and Niemeyer, {Charlotte M.} and Christian Flotho and Christoph Plass",

note = "Publisher Copyright: {\textcopyright} 2014 Landes Bioscience.",

year = "2014",

doi = "10.4161/epi.29941",

language = "English",

volume = "9",

pages = "1252--1260",

journal = "Epigenetics",

issn = "1559-2294",

publisher = "Landes Bioscience",

number = "9",

}

Poetsch, AR, Lipka, DB, Witte, T, Claus, R, Nöllke, P, Zucknick, M, Olk-Batz, C, Fluhr, S, Dworzak, M, De Moerloose, B, Starý, J, Zecca, M, Hasle, H, Schmugge, M, van den Heuvel-Eibrink, MM, Locatelli, F, Niemeyer, CM, Flotho, C & Plass, C 2014, 'RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia', Epigenetics, vol. 9, nr. 9, blz. 1252-1260. https://doi.org/10.4161/epi.29941

TY - JOUR

T1 - RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia

AU - Poetsch, Anna R.

AU - Lipka, Daniel B.

AU - Witte, Tania

AU - Claus, Rainer

AU - Nöllke, Peter

AU - Zucknick, Manuela

AU - Olk-Batz, Christiane

AU - Fluhr, Silvia

AU - Dworzak, Michael

AU - De Moerloose, Barbara

AU - Starý, Jan

AU - Zecca, Marco

AU - Hasle, Henrik

AU - Schmugge, Markus

AU - van den Heuvel-Eibrink, Marry M.

AU - Locatelli, Franco

AU - Niemeyer, Charlotte M.

AU - Flotho, Christian

AU - Plass, Christoph

PY - 2014

Y1 - 2014

N2 - Aberrant DNA methylation at specific genetic loci is a key molecular feature of juvenile myelomonocytic leukemia (JMML) with poor prognosis. Using quantitative high-resolution mass spectrometry, we identified RASA4 isoform 2, which maps to chromosome 7 and encodes a member of the GAP1 family of GTPase-activating proteins for small G proteins, as a recurrent target of isoform-specific DNA hypermethylation in JMML (51% of 125 patients analyzed). RASA4 isoform 2 promoter methylation correlated with clinical parameters predicting poor prognosis (older age, elevated fetal hemoglobin), with higher risk of relapse after hematopoietic stem cell transplantation, and with PTPN11 mutation. The level of isoform 2 methylation increased in relapsed cases after transplantation. Interestingly, most JMML cases with monosomy 7 exhibited hypermethylation on the remaining RASA4 allele. The results corroborate the significance of epigenetic modifications in the phenotype of aggressive JMML.

AB - Aberrant DNA methylation at specific genetic loci is a key molecular feature of juvenile myelomonocytic leukemia (JMML) with poor prognosis. Using quantitative high-resolution mass spectrometry, we identified RASA4 isoform 2, which maps to chromosome 7 and encodes a member of the GAP1 family of GTPase-activating proteins for small G proteins, as a recurrent target of isoform-specific DNA hypermethylation in JMML (51% of 125 patients analyzed). RASA4 isoform 2 promoter methylation correlated with clinical parameters predicting poor prognosis (older age, elevated fetal hemoglobin), with higher risk of relapse after hematopoietic stem cell transplantation, and with PTPN11 mutation. The level of isoform 2 methylation increased in relapsed cases after transplantation. Interestingly, most JMML cases with monosomy 7 exhibited hypermethylation on the remaining RASA4 allele. The results corroborate the significance of epigenetic modifications in the phenotype of aggressive JMML.

KW - DNA methylation

KW - Epigenetics

KW - JMML

KW - juvenile myelomonocytic leukemia

KW - RASA4

UR - http://www.scopus.com/inward/record.url?scp=84908215285&partnerID=8YFLogxK

U2 - 10.4161/epi.29941

DO - 10.4161/epi.29941

M3 - Article

C2 - 25147919

AN - SCOPUS:84908215285

SN - 1559-2294

VL - 9

SP - 1252

EP - 1260

JO - Epigenetics

JF - Epigenetics

IS - 9

ER -

RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia

Samenvatting

Toegang tot document

Vingerafdruk

Citeer dit